2. Urinary biomarkers for endometriosis.
| Angiogenesis/Growth factors and their receptors | |
| VEGF‐A (vascular endothelial growth factor ‐ A)1 | |
| sFlt‐1 [sVEGFR‐1] (soluble fms‐like tyrosine kinase or variant of VEGF receptor 1)2 | |
| Cell adhesion molecules and other matrix‐related proteins | |
| MMP‐2 (matrix metalloproteinase‐2)2 | |
| MMP‐9 (matrix metalloproteinase‐9)2 | |
| MMP‐9/ NGAL (matrix metalloproteinase‐9/neutrophil gelatinase‐associated lipocalin)2 | |
| Cytokines | |
| TNF‐alpha (tumour necrosis factor alfa)1 | |
| Cytoskeleton molecules | |
| CK‐19 or CYFRA 21‐1 (Cytokeratin‐19)1 | |
| High throughput markers | |
| Proteome | |
| Oxidative stress markers | |
| 8‐iso‐PGF2a (8‐iso‐prostaglandin F2a)2 | |
| Other Peptides/proteins | |
| VDBP (vitamin D binding protein) | |
| NNE (enolase I) | |
| Collagen precursors | |
| Prealbumin2 | |
| Alpha 1 antitrypsin2 | |
| Chain A solution structure of Bb' domains of human protein disulfide isomerase2 | |
|
1 Urinary biomarkers that did not exhibit differential expression in endometriosis 2 Urinary biomarkers that exhibited differential expression in endometriosis, but for which the diagnostic estimates were not available |